Publications Peetra Magnusson

Publications in DiVA

Publications in PubMed

Selected publications:

  1. Immunothrombosis and vascular heterogeneity in cerebral cavernous malformation. Globisch MA, Oneyogaziri FC, Jauhiainen S, Yau A, Orsenigo F, Conze L, Arce M, Coarada M, Smith R, Rorsman C, Sundell V, Fernando D, Daniel G, Mattsson O, Savander H, Wanders A, Rezai Jahromi B, Laakso A, Niemelä M, Dejana E. and Magnusson PU. Blood. 2022, 140(20):2154-2169. This article was awarded with a cover illustration. (see also press release about the paper).
  2. Heparin conjugate pretreatment of kidneys from deceased donors before transplantation: Results from the first-in-human randomized phase I trial. Sedigh A, Lundgren T, Lindnér P, Nordström J, Magnusson PU, Jönsson J, Carlsson F, Ploeg R. and Lorant T. Transplant Direct. 2022, 9(1):e1403.
  3. Slow-Closing Clip for the Treatment of Nonsaccular Vertebrobasilar Aneurysms: A Retrospective Case Series. Rezai Jahromi B, Dashti R, Rustemi O, Silva JM, Srinivasan VM, Tulamo R, Kozyrev DA, Jauhiainen S, Magnusson PU, Arce M, Kaukovalta H, Schwartz C, Numminen J, Sarpaneva S, Hirvelä V, Lawton MT, Tanikawa R, Niemelä M. and Hernesniemi J. World Neurosurgery. 2022, 168:e645-e655.
  4. Inflammation and neutrophil extracellular traps in cerebral cavernous malformation. Yau ACY, Globisch MA, Onyeogaziri FC, Conze LL, Smith R, Jauhiainen S, Corada M, Orsenigo F, Huang H, Herre M, Olsson AK, Malinverno M, Sundell V, Rezai Jahromi B, Niemelä M, Laakso A, Garlanda C, Mantovani A, Lampugnani MG, Dejana E, Magnusson PU. Cell Mol Life Sci. 2022, 79(4):206. (see also press release about the paper).
  5. Oldenburg j, Malinverno M, Globisch MA, Madera C, Corada M, Orsenigo F, Conze LL, Rorsman C, Sundell V, Arce M, Smith RO, Yau ACY, PhD, Hulsart Billström G, Öhman Mägi C, Beznoussenko GV, Mironov AA, Fernando D, Daniel G, Olivari D, Fumagalli F, Lampugnani MG, Dejana E, Magnusson P. Propranolol reduces the development of lesions and rescues barrier function in Cerebral Cavernous Malformations - a preclinical study. Stroke. 2021, 52(4):1418-1427. (see also press release about the paper)
  6. Stancic B, Qvarfordt B, Berglund MM, Brenden N, Sydow Bäckman M, Fransson M, Nordling N, Magnusson PU. The blood endothelial cell chamber – An innovative system to study immune responses in drug development. Int. Immunopharmacol. 2021, 90:107237.
  7. Orsenigo F, Conze LL, Jauhiainen S, Corada M, Lazzaroni F, Malinverno M, Sundell V, Cunha SI, Brännström J, Globisch MA, Maderna C, Lampugnani MG, Magnusson PU, Dejana E. Mapping endothelial-cell diversity in Cerebral Cavernous Malformations at single cell resolution. eLife. 2020, 9:e61413.
  8. Malinverno M, Maderna C, Abu Taha A, Corada M, Orsenigo F, Valentino M, Pisati F, Fusco C, Graziano P, Giannotta M, Yu QC, Zeng YA, Lampugnani MG, Magnusson PU, Dejana E. Endothelial cell clonal expansion in the development of cerebral cavernous malformations. Nat Commun. 2019, 10(1):2761.
  9. Corada M, Orsenigo F, Bhat GP, Conze LL, Breviario F, Cunha SI, Claesson-Welsh L, Beznoussenko GV, Mironov AA, Bacigaluppi M, Martino G, Pitulescu ME, Adams RH, Magnusson P, Dejana E.Fine-Tuning of Sox17 and Canonical Wnt Coordinates the Permeability Properties of the Blood-Brain Barrier. Circ Res. 2019, 124(4):511-525.
  10. Nordling S, Brännström J, Carlsson F, Lu B, Salvaris E, Wanders A, Buijs J, Estrada S, Tolmachev V, Cowan PJ, Lorant T, Magnusson PU. Enhanced protection of the renal vascular endothelium improves early outcome in kidney transplantation: Preclinical investigations in pig and mouse. Sci Rep. 2018, 8(1):5220.
Last modified: 2023-03-20
Print